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Introduction
Disseminated human cytomegalovirus (HCMV)' infections occur at a high rate in immunosuppressed, namely AIDS, patients (1) . Such infections are diagnosed by determination of HCMV antigenemia (i.e., detection of HCMV antigens, and namely pp65, in PMN and mononuclear [MN] leukocytes [2] [3] [4] ]), and viremia (i.e., HCMV isolation from PMN and MN [ 5, 1. Abbreviations used in this paper: APAAP, alkaline phosphatase-antialkaline phosphatase; CSF, cerebrospinal fluid; ECG, endothelial giant cells; HCMV, human cytomegalovirus; HLTR, heart-lung transplant recipients; HLTR, heart transplant recipients; HUVEC, human umbilical vein endothelial cells; M/M, monocyte/macrophages; vWf, von Willebrand factor. 6]). Both antigenemia and viremia have been quantitated, and a correlation between high levels of these two parameters and presence or appearance of clinical symptoms has been observed (7) . On This report describes the detection of a new marker of HCMV infection in blood ofimmunosuppressed patients, consisting of HCMV-infected circulating endothelial giants cells (EGC), which are found in greater proportions concomitantly with an organ syndrome. Methods Patients. 10 heart or heart-lung transplant recipients (HTR or HLTR) and 15 AIDS patients were included in the study. Of these, five HTR and two HLTR, as well as three AIDS patients underwent clinical and virologic follow up for HCMV infection. Patients undergoing antiviral treatment received either ganciclovir (10 mg/kg per d) or foscarnet ( 180 mg/kg per d) as induction treatment. Quantitation of HCMV in blood was achieved by sequential determination of pp65-antigenemia, viremia, and count of HCMV-infected EGC.
pp65-Antigenemia. Quantitation of pp65-antigenemia was achieved by using a fluorescence microscope to count the number of PMN positive for HCMV pp65/2 x 105 cells examined on cytospin preparations stained according to a recently reported procedure (4).
Viremia. Viremia was quantified by inoculating 2 X I05 PMN onto human embryonic lung fibroblast cell cultures according to the shell vial technique and then counting the number of fibroblasts positive for HCMV immediate-early antigen p72, 16-24 h postinfection (5) . A significant correlation between levels ofpp65-antigenemia and viremia has been previously reported (5) .
Virus isolation. Conventional virus isolation from blood leukocytes and other clinical samples including bioptic specimens was performed on human embryonic lung fibroblast cell cultures after appearance of cytopathic effect within 2 wk postinfection. Negative cultures were blindly passaged for another 2-wk period. HCMV was identified as reported (5) .
Cytospin preparations ofMNfor detection ofEGC. Ficoll-separated MN were adjusted to a concentration of 2 x 106 cells/ml. Cytospin preparations were obtained by centrifugation of 2 x I05 cells onto glass slides ( 100 ,ul/slide) at 90 g for 3 min by using a cytocentrifuge (Cytospin 2; Shandon Southern Products Ltd. Runcorn, United Kingdom). Slides were air dried for 2 30 min and then fixed. To obtain better immunostaining patterns, cells were fixed using 5% paraformaldehyde and then permeabilized with 0.5% NP-40 according to a reported procedure (4). After air drying for 2 20 min, slides were ready for staining or storage at -800C.
Endothelial cells. Human umbilical vein endothelial cells (HU-VEC) were isolated according to a reported procedure (8) . Cultures were propagated in endothelial cell growth medium, consisting of M-199 supplemented with 20% FCS, 1% endothelial cell culture supernatant (9), and 10 U/ml sodium heparin. Growing surfaces for HU-VEC were pretreated with 0.2% gelatin. Cultures at passage 3 were used in the reported experiments. HUVEC were infected using a multiplicity of infection of 1-5 of the reference strain AD 169 previously passaged onto human embryonic fibroblast cell cultures.
Monoclonal antibodies. Two mAbs were used for phenotype identification of EGC: one, referred to as PAL-E (Sera-lab, Crawly Down, Sussex, United Kingdom), specific for endothelium ofcapillaries, venules and medium-sized and small veins, but neither recognizing medium-sized and small arteries and arterioles nor megakaryocytes and platelets (10) ; the other one specific for von Willebrand factor (vWf)(M616; Dako A/S, Glostrup, Denmark). The same two mAbs were used for immunostaining of HCMV-infected HUVEC, as well as tissue sections. Identification of HCMV proteins present in EGC, as well as in HUVEC used the following HCMV-specific mAbs developed in the laboratory: (a) mAbs to the major immediate-early protein p72 ( 11); (b) mAbs to the lower matrix phosphoprotein pp65 ( 11); (c) mAbs to the major DNA-binding protein p52 (12) ; a single mAb to a late viral protein, p150 (5) . An mAb recognizing an early HCMV antigen (M757, Dako A/S) (13), as well as the mAb to pl50 were used for tissue sections.
Immunostaining procedure. The immunofluorescence technique was used routinely, while the immunoperoxidase method was often done in parallel, according to a recently reported procedure (4) . For the immunofluorescence method, cytospin preparations were first reacted for 30 min at 37°C with optimal dilutions of different mAbs and then, after washings, with a fluorescein-conjugated F(ab')2 fragment goat anti-mouse IgG (Organon Teknika, Cappel Laboratories, West Chester, PA) optimally diluted in PBS-0.0005% Evans blue. The immunoperoxidase method followed the same procedure, using a peroxidase-conjugated F(ab')2 fragment goat anti-mouse IgG (Cappel Laboratories). After the second step of the reaction, the chromogensubstrate solution (diaminobenzidine-H202 in 0.05 M Tris [pH7.6]) was added for 5 min at room temperature. Finally, in both procedures, slides were mounted and positive EGC were counted under an ultraviolet or a light microscope, respectively. Details ofother immunostaining techniques such as alkaline phosphatase-antialkaline phosphatase (APAAP) have been previously reported (4). Histologic and immunohistochemical procedures for staining of deparaffinized tissue sections were performed according to standard methods. Double immunostaining of EGC for HCMV and endothelial cell antigen was performed by first reacting formalin-fixed cells with a guinea pig immune serum to HCMV capsid antigen (developed in the laboratory), which was detected by the IPA technique (brown nuclear staining). Then, same cell preparations were reacted with mAb PAL-E, which was revealed by the APAAP procedure (red cytoplasmic granular staining).
Results
Detection ofHCMV-infectedEGCin immunocompromisedpatients. The presence of HCMV-infected EGC ( Fig. 1 A) (PAL-E) specifically recognizing an endothelial cell protein, as well as with a mAb specific for vWf. As shown in Fig. 2 , A and B, the staining pattern obtained using PAL-E and the APAAP method was comparable in both EGC and HUVEC. Similar results were obtained using mAb to vWf. On this basis, EGC were considered most likely to be of endothelial origin. Detection ofHCMV immediate-early, early, and late structural antigens in EGC. Level ofHCMV replication in EGC was determined by reacting multiple MN cytospin preparations with high, low, and negative number ofEGC, with mAbs developed in the laboratory and previously characterized to react with the major immediate-early protein p72, the major DNA binding protein p52, the early structural lower matrix phos- (Fig. 1 B) , again according to a staining pattern well known in infected cultured human fibroblasts (11) . In parallel, the same mAbs were tested on HCMV-infected HUVEC cultured in vitro. As shown in Fig. 2 , C-F, the same staining patterns observed in EGC were found in HCMV-infected HUVEC. Double immunostaining of EGC for HCMV (brown nucleus) and endothelial antigen (red cytoplasm) is shown in Fig. 3, A (Table IV, blood collection, in patient 1 (Table IV) . While the number of pp65-positive PMN in blood and CSF was comparable ( -800), there were only two EGC in blood as compared to 50 in CSF. After ganciclovir treatment, EGC disappeared from CSF, whereas a few pp65-positive PMN persisted both in blood and CSF. Thus, EGC appeared to accumulate in CSF because of nervous system involvement.
Apparent identity ofEGC with HCMV-infected endothelial cells detachingfrom wall ofsmall vessels in histologic sections. Multiple observations performed on bioptic or autoptic tissues according to routine histologic procedures showed that endothelial cells of capillary or small vessels are primary targets of viral infection in organ localizations ofHCMV infection. Endothelial cells enlarge with progression of HCMV infection and, when nuclear inclusion bodies are detected, cells round up and detach from wall inside the vessel lumen (Fig. 4, A and B) . Immunocytochemical identification of the phenotype of these cells with mAb to vWf showed that they are true endothelial cells infected by HCMV (Fig. 5) Figure 3 . Double immunostaining of EGC for HCMV, using a guinea pig immune serum to a capsid antigen and the immunoperoxidase technique (brown nucleus), and for endothelial antigen, using mAb PAL-E and the APAAP procedure (red cytoplasm). X 1,000.
are present, suggesting a full viral replication cycle. However, only a minor part of HCMV-infected EGC reacted strongly with mAb to vWf. This was most likely caused by the loss of vWfin HCMV-infected endothelial cells, as reported in in vitro studies ( 14) . Thus, these findings support the view that EGC are cells of endothelial origin circulating in peripheral blood after detachment from the vessel wall resulting from HCMV infection.
Discussion HCMV-infected EGC have been identified in the peripheral blood of immunocompromised patients with systemic HCMV infection and are often detected concomitantly with a HCMV organ syndrome. At the moment, these results, given the limited number of patients examined, are only preliminary and their clinical significance must be confirmed on a more extended series of patients. EGC represent a new marker of HCMV infections, which appears highly interesting from a pathogenetic standpoint. It has been reported that endothelial cells are a common target of HCMV infection in vivo, regardless ofthe organ involved ( 15, 16) , and that they might represent a site of HCMV latency in immunocompetent subjects (17) (18) (19) . This hypothesis seems to be supported by recent data obtained using the polymerase chain reaction, which showed the presence of HCMV DNA in blood vessels of most HCMV-seropositive subjects (20, 21 ) . It is well known that in immunosuppressed, and namely AIDS patients with disseminated HCMV infection, HCMV inclusion-bearing endothelial cells are often detected in multiple organs (22, 23) .
The new finding reported in this paper is that HCMV-infected endothelial cells progressively enlarge till they detach from the vessel wall and enter the blood stream. EGC detected in peripheral blood show advanced CPE and often undergo initial lysis with frequent cytoplasmic shedding. Identification of the endothelial phenotype and detection of early and late viral antigens in both EGC and HCMV-infected cells of small vessel walls support the hypothesis that EGC are the same cells observed in histologic sections.
It seems reasonable to hypothesize that in vivo endothelial cells may be infected by circulating infected PMN and monocyte/macrophages (M/M). While it is well known that HCMV can be isolated from M/M as well as from PMN (6, 24) , it is commonly recognized that infectious virus and viral material detected in PMN of immunocompromised patients are mostly uptaken by phagocytosis (25) , although HCMV early replicative events do seem to occur in PMN (6, 26) . This assumption mainly applies to the HCMV lower matrix phosphoprotein pp65 detected in nuclei ofinfected PMN. The same event can occur in M/M which, however, have been shown to become permissive for HCMV replication in vitro when differentiation into macrophages occurs (27) or macrophage treatment with therapeutic levels of hydrocortisone is performed (28). overt organ syndrome seems to suggest, albeit preliminarily, an association between EGC and organ involvement. In AIDS patients with HCMV retinitis, the EGC number was low in most patients examined. This seems to be in agreement with a recent report showing that levels ofcirculating HCMV DNA in blood leukocytes is relatively low in AIDS patients with HCMV retinitis as compared to patients with HCMV visceral organ involvement (29) . These results may partly find their biological basis in the presence of EGC in some of the leukocyte fractions examined. A correlation between viral DNA in blood and number or presence of EGC should be investigated in these patients.
The case of patient 1 in Table IV showing nervous system involvement with a high EGC count in CSF and absence of EGC in blood, seems to shed some light on the association between CSF EGC and a HCMV organ syndrome of the nervous system. While EGC enter blood stream and circulate in visceral HCMV disease, in CNS syndromes EGC remain localized in CSF. -,4,. t9l"
In conclusion, EGC provide a new parameter for the study of the pathogenesis of HCMV infections in immunocompromised patients. In addition, EGC may represent a helpful early clinical marker of HCMV localization, providing the clinician with a quantitative morphological parameter that can be monitored and used to determine antiviral treatment strategy in visceral organ involvement.
